COVID-19 has been one of the deadliest pandemics in the history of the world, uncontrollably claiming millions of lives while leaving the remaining in perpetual fear. Healthcare professionals and researchers have been working tirelessly over the last few months to develop effective medicines to combat this virus. Thanks to their persistence and hard work, we now have a canvas of breakthrough medicines that have the potential to transform the way we treat COVID-19. In this article, we’ll discuss five of the most promising breakthrough medicines for treating COVID-19.
1. Remdesivir
Remdesivir is an antiviral medication that received FDA approval as an emergency drug in May 2020. The drug has demonstrated potential in treating COVID-19 by reducing the duration of hospitalization and lowering the mortality rate. Clinical studies have also shown the drug to be effective in reducing the severity of respiratory symptoms associated with COVID-19.
2. Dexamethasone
Dexamethasone is a steroid medication that was found to be effective in treating COVID-19 by lowering the mortality rate. According to a UK study, the medication was able to reduce mortality by around 20% for patients on ventilators and by around 10% for those requiring oxygen therapy.
3. Tocilizumab
Tocilizumab is a medication used to treat rheumatoid arthritis that has also been shown to be effective in treating COVID-19. The medication works by suppressing the immune system’s overreaction to the virus, thereby reducing inflammation. In clinical studies, the medication was found to accelerate recovery and lower the mortality rate.
4. Baricitinib
Baricitinib is a medication that is primarily used to treat rheumatoid arthritis. However, it has shown potential in treating COVID-19 by reducing inflammation caused by the virus. The medication has also been found to reduce the duration of recovery in patients infected with COVID-19.
5. Convalescent plasma
Convalescent plasma therapy involves using plasma from recovered COVID-19 patients to treat patients still fighting the virus. The plasma contains antibodies produced by the immune system to fight the virus, which can help patients still fighting the disease. This therapy has been found to reduce the mortality rate of COVID-19 patients significantly.
Conclusion
COVID-19 has brought the world to its knees, claiming countless lives and leaving a lasting impact on the world order. However, the development of breakthrough medicines offers a ray of hope in these trying times. Remdesivir, Dexamethasone, Tocilizumab, Baricitinib and Convalescent plasma have shown immense potential in treating COVID-19, offering healthcare professionals and researchers much-needed relief in their fight against this deadly pandemic. With continued research, these and other medicines can help change the course of the COVID-19 pandemic, bringing an end to an unprecedented era of fear and uncertainty.
(Note: Do you have knowledge or insights to share? Unlock new opportunities and expand your reach by joining our authors team. Click Registration to join us and share your expertise with our readers.)
Speech tips:
Please note that any statements involving politics will not be approved.